# Nitric Oxide During Bypass for Arterial Switch Operation

> **NCT03661385** · PHASE3 · COMPLETED · sponsor: **Murdoch Childrens Research Institute** · enrollment: 300 (actual)

## Conditions studied

- Low Cardiac Output Syndrome
- Transposition of Great Vessels

## Interventions

- **DRUG:** Nitric Oxide

## Key facts

- **NCT ID:** NCT03661385
- **Lead sponsor:** Murdoch Childrens Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-11
- **Primary completion:** 2022-03-23
- **Final completion:** 2023-04-23
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2024-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03661385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03661385, "Nitric Oxide During Bypass for Arterial Switch Operation". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03661385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*